

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.36286615 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.36286615 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.62612626 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.88547351 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.49273797 |
| 6 | negative regulation of cell killing (GO:0031342) | 4.49273797 |
| 7 | detection of bacterium (GO:0016045) | 4.34329285 |
| 8 | proline biosynthetic process (GO:0006561) | 4.33133518 |
| 9 | detection of other organism (GO:0098543) | 4.29409044 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 4.06478440 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.00095466 |
| 12 | response to peptidoglycan (GO:0032494) | 3.91768005 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 3.81389955 |
| 14 | positive regulation of protein homooligomerization (GO:0032464) | 3.72965461 |
| 15 | embryonic process involved in female pregnancy (GO:0060136) | 3.70296020 |
| 16 | response to type I interferon (GO:0034340) | 3.69448966 |
| 17 | leukocyte aggregation (GO:0070486) | 3.67971211 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 3.66414874 |
| 19 | type I interferon signaling pathway (GO:0060337) | 3.64976310 |
| 20 | cellular response to type I interferon (GO:0071357) | 3.64976310 |
| 21 | germinal center formation (GO:0002467) | 3.61653416 |
| 22 | cellular response to zinc ion (GO:0071294) | 3.59776461 |
| 23 | proline metabolic process (GO:0006560) | 3.57710623 |
| 24 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.57483770 |
| 25 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.56282818 |
| 26 | detection of external biotic stimulus (GO:0098581) | 3.51824283 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.45797888 |
| 28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.45461620 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.36422534 |
| 30 | regulation of integrin activation (GO:0033623) | 3.34835103 |
| 31 | response to muramyl dipeptide (GO:0032495) | 3.31760312 |
| 32 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.28263100 |
| 33 | positive thymic T cell selection (GO:0045059) | 3.22563578 |
| 34 | T cell migration (GO:0072678) | 3.19978269 |
| 35 | NIK/NF-kappaB signaling (GO:0038061) | 3.19880905 |
| 36 | negative regulation of T cell mediated immunity (GO:0002710) | 3.18372830 |
| 37 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.16293239 |
| 38 | regulation of T cell tolerance induction (GO:0002664) | 3.14030369 |
| 39 | defense response to protozoan (GO:0042832) | 3.10704154 |
| 40 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.10509489 |
| 41 | regulation of antigen processing and presentation (GO:0002577) | 3.09585527 |
| 42 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.09062180 |
| 43 | positive regulation of humoral immune response (GO:0002922) | 3.08244388 |
| 44 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06889051 |
| 45 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.06349954 |
| 46 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.06132756 |
| 47 | detection of biotic stimulus (GO:0009595) | 3.04042045 |
| 48 | positive regulation of type 2 immune response (GO:0002830) | 3.04005423 |
| 49 | response to interferon-alpha (GO:0035455) | 3.01768852 |
| 50 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.01451290 |
| 51 | positive regulation of interferon-alpha production (GO:0032727) | 3.01179750 |
| 52 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.01142076 |
| 53 | response to host immune response (GO:0052572) | 3.01142076 |
| 54 | negative regulation of interleukin-12 production (GO:0032695) | 2.96408002 |
| 55 | sulfur amino acid catabolic process (GO:0000098) | 2.96067156 |
| 56 | negative thymic T cell selection (GO:0045060) | 2.94701725 |
| 57 | negative T cell selection (GO:0043383) | 2.94600710 |
| 58 | mannose metabolic process (GO:0006013) | 2.94088647 |
| 59 | response to protozoan (GO:0001562) | 2.93512316 |
| 60 | detection of molecule of bacterial origin (GO:0032490) | 2.92120034 |
| 61 | * negative regulation of viral genome replication (GO:0045071) | 2.91213060 |
| 62 | regulation of mast cell degranulation (GO:0043304) | 2.90675413 |
| 63 | regulation of tolerance induction (GO:0002643) | 2.89862919 |
| 64 | negative regulation of type 2 immune response (GO:0002829) | 2.88756936 |
| 65 | regulation of type 2 immune response (GO:0002828) | 2.88478218 |
| 66 | response to host (GO:0075136) | 2.85908535 |
| 67 | response to host defenses (GO:0052200) | 2.85908535 |
| 68 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.85908535 |
| 69 | myeloid dendritic cell differentiation (GO:0043011) | 2.84931947 |
| 70 | cellular response to interferon-gamma (GO:0071346) | 2.84816423 |
| 71 | regulation of interferon-alpha production (GO:0032647) | 2.84660984 |
| 72 | regulation of cholesterol homeostasis (GO:2000188) | 2.84421961 |
| 73 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.84304538 |
| 74 | regulation of protein homooligomerization (GO:0032462) | 2.83606546 |
| 75 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.82921666 |
| 76 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.82847699 |
| 77 | immunoglobulin mediated immune response (GO:0016064) | 2.79637627 |
| 78 | myeloid cell activation involved in immune response (GO:0002275) | 2.79014883 |
| 79 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.77351168 |
| 80 | transcription from mitochondrial promoter (GO:0006390) | 2.77196173 |
| 81 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.76349712 |
| 82 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.75506208 |
| 83 | cellular response to interferon-alpha (GO:0035457) | 2.74474905 |
| 84 | cellular extravasation (GO:0045123) | 2.74253369 |
| 85 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.69304075 |
| 86 | tolerance induction (GO:0002507) | 2.68397689 |
| 87 | regulation of leukocyte degranulation (GO:0043300) | 2.68024671 |
| 88 | myeloid dendritic cell activation (GO:0001773) | 2.67753809 |
| 89 | respiratory burst (GO:0045730) | 2.67589008 |
| 90 | response to interferon-gamma (GO:0034341) | 2.67145491 |
| 91 | cellular response to virus (GO:0098586) | 2.66707222 |
| 92 | positive regulation of interferon-beta production (GO:0032728) | 2.66581980 |
| 93 | neutrophil activation (GO:0042119) | 2.66408607 |
| 94 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.66135561 |
| 95 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.65251644 |
| 96 | regulation of cholesterol storage (GO:0010885) | 2.64570421 |
| 97 | macrophage activation (GO:0042116) | 2.64398708 |
| 98 | response to interferon-beta (GO:0035456) | 2.64301089 |
| 99 | lymphocyte chemotaxis (GO:0048247) | 2.63854537 |
| 100 | positive regulation by symbiont of host defense response (GO:0052509) | 2.62311865 |
| 101 | modulation by symbiont of host defense response (GO:0052031) | 2.62311865 |
| 102 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.62311865 |
| 103 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.62311865 |
| 104 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.62311865 |
| 105 | modulation by symbiont of host immune response (GO:0052553) | 2.62311865 |
| 106 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.60716479 |
| 107 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.60549780 |
| 108 | regulation of response to interferon-gamma (GO:0060330) | 2.58877737 |
| 109 | positive regulation of protein oligomerization (GO:0032461) | 2.57967008 |
| 110 | regulation of B cell differentiation (GO:0045577) | 2.57871574 |
| 111 | negative regulation of type I interferon production (GO:0032480) | 2.57624424 |
| 112 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.57160962 |
| 113 | embryonic placenta development (GO:0001892) | 2.54993990 |
| 114 | thymic T cell selection (GO:0045061) | 2.54791382 |
| 115 | positive regulation of B cell differentiation (GO:0045579) | 2.48198259 |
| 116 | positive regulation of antigen processing and presentation (GO:0002579) | 2.46640238 |
| 117 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.44609188 |
| 118 | low-density lipoprotein particle clearance (GO:0034383) | 2.44151347 |
| 119 | plasma lipoprotein particle assembly (GO:0034377) | 2.44003092 |
| 120 | valine metabolic process (GO:0006573) | 2.41726984 |
| 121 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.40819202 |
| 122 | leukocyte cell-cell adhesion (GO:0007159) | 2.40342641 |
| 123 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.40310000 |
| 124 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.39259951 |
| 125 | L-phenylalanine metabolic process (GO:0006558) | 2.38619728 |
| 126 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.38619728 |
| 127 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.37685689 |
| 128 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.37072600 |
| 129 | oxidative demethylation (GO:0070989) | 2.35153451 |
| 130 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.33692316 |
| 131 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.33391057 |
| 132 | positive T cell selection (GO:0043368) | 2.32861825 |
| 133 | B cell mediated immunity (GO:0019724) | 2.32054601 |
| 134 | phospholipid efflux (GO:0033700) | 2.31005307 |
| 135 | T cell selection (GO:0045058) | 2.30643015 |
| 136 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.29872996 |
| 137 | negative regulation of stress fiber assembly (GO:0051497) | 2.29756591 |
| 138 | B cell receptor signaling pathway (GO:0050853) | 2.28812311 |
| 139 | intestinal cholesterol absorption (GO:0030299) | 2.28422751 |
| 140 | negative regulation of innate immune response (GO:0045824) | 2.27662398 |
| 141 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.26994218 |
| 142 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.26852759 |
| 143 | protein carboxylation (GO:0018214) | 2.26195729 |
| 144 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.26195729 |
| 145 | positive regulation of isotype switching (GO:0045830) | 2.26027434 |
| 146 | cellular response to interferon-beta (GO:0035458) | 2.25613469 |
| 147 | complement activation, alternative pathway (GO:0006957) | 2.24574316 |
| 148 | alkaloid metabolic process (GO:0009820) | 2.24022528 |
| 149 | regulation of podosome assembly (GO:0071801) | 2.23937115 |
| 150 | mature B cell differentiation (GO:0002335) | 2.23754442 |
| 151 | cholesterol efflux (GO:0033344) | 2.23210815 |
| 152 | response to interleukin-15 (GO:0070672) | 2.22920238 |
| 153 | protein-lipid complex assembly (GO:0065005) | 2.22763822 |
| 154 | plasma lipoprotein particle clearance (GO:0034381) | 2.21035252 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.65782560 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.40000782 |
| 3 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.16427751 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.97594310 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.87574170 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.74969810 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.72870639 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.70064237 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.61404216 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.60645422 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.43823657 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.31293590 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.28061434 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.24831171 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.15817967 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.15253351 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.08718550 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06905909 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.06594072 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05824169 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.05510271 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.04551026 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.97779810 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.94217628 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.92655893 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90707386 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.90705055 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87914158 |
| 29 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.83583041 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80281439 |
| 31 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.76620584 |
| 32 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.76509129 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.74652445 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.69461508 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.68153793 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.65680988 |
| 37 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.64399222 |
| 38 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.64114119 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.64001531 |
| 40 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.62616993 |
| 41 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.62512340 |
| 42 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.62291598 |
| 43 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.60529379 |
| 44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.59400931 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59146808 |
| 46 | * MYB_26560356_Chip-Seq_TH2_Human | 1.54410682 |
| 47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.52437277 |
| 48 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.47785417 |
| 49 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46671759 |
| 50 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.46159263 |
| 51 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.42764609 |
| 52 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.41552490 |
| 53 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40672694 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.39478121 |
| 55 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.38189173 |
| 56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38086692 |
| 57 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.37687480 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36746658 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36237881 |
| 60 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.33999795 |
| 61 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.32976384 |
| 62 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.31844301 |
| 63 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.31624131 |
| 64 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.30770686 |
| 65 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.29035724 |
| 66 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.28993041 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27962663 |
| 68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26596422 |
| 69 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.25402476 |
| 70 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25334873 |
| 71 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.25099942 |
| 72 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24896274 |
| 73 | * P68_20966046_ChIP-Seq_HELA_Human | 1.23439822 |
| 74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23311542 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23017165 |
| 76 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21176905 |
| 77 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20281489 |
| 78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19968599 |
| 79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18605183 |
| 80 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18551257 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16069949 |
| 82 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15133503 |
| 83 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.15080493 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14579192 |
| 85 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13551034 |
| 86 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.12510186 |
| 87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12173042 |
| 88 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.11992080 |
| 89 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09206491 |
| 90 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09105814 |
| 91 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08334880 |
| 92 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06868530 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06638374 |
| 94 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.06559531 |
| 95 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05641283 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04690048 |
| 97 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03894305 |
| 98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03571334 |
| 99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00804938 |
| 100 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00156096 |
| 101 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.99922014 |
| 102 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.99506720 |
| 103 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.99184825 |
| 104 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98820196 |
| 105 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97502789 |
| 106 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97448548 |
| 107 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96153834 |
| 108 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95532842 |
| 109 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.95309733 |
| 110 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.94791662 |
| 111 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.94189264 |
| 112 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.94168321 |
| 113 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93561002 |
| 114 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93478849 |
| 115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92763974 |
| 116 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91993648 |
| 117 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89486067 |
| 118 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89229855 |
| 119 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88726597 |
| 120 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.88296335 |
| 121 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.86637965 |
| 122 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.85640755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000685_abnormal_immune_system | 2.98330392 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.85452694 |
| 3 | MP0009278_abnormal_bone_marrow | 2.46358917 |
| 4 | MP0003436_decreased_susceptibility_to | 2.43626481 |
| 5 | MP0005360_urolithiasis | 2.42764876 |
| 6 | MP0009785_altered_susceptibility_to | 2.38258740 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.34911959 |
| 8 | MP0005365_abnormal_bile_salt | 2.33055712 |
| 9 | MP0006082_CNS_inflammation | 2.30130078 |
| 10 | MP0002166_altered_tumor_susceptibility | 2.28457780 |
| 11 | MP0009840_abnormal_foam_cell | 2.22211740 |
| 12 | MP0001790_abnormal_immune_system | 2.17279085 |
| 13 | MP0005387_immune_system_phenotype | 2.17279085 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.17212665 |
| 15 | MP0005085_abnormal_gallbladder_physiolo | 2.14294049 |
| 16 | MP0001800_abnormal_humoral_immune | 2.07958401 |
| 17 | MP0005025_abnormal_response_to | 2.05772779 |
| 18 | MP0001545_abnormal_hematopoietic_system | 2.02742868 |
| 19 | MP0005397_hematopoietic_system_phenotyp | 2.02742868 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.00098619 |
| 21 | MP0005451_abnormal_body_composition | 1.99270026 |
| 22 | MP0005058_abnormal_lysosome_morphology | 1.97205690 |
| 23 | MP0005671_abnormal_response_to | 1.96520640 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.96031327 |
| 25 | MP0003724_increased_susceptibility_to | 1.96003579 |
| 26 | MP0002405_respiratory_system_inflammati | 1.86573286 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.86206104 |
| 28 | MP0002723_abnormal_immune_serum | 1.80366948 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.79298058 |
| 30 | MP0004947_skin_inflammation | 1.76782336 |
| 31 | MP0003303_peritoneal_inflammation | 1.76131936 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.75889558 |
| 33 | MP0002419_abnormal_innate_immunity | 1.74029129 |
| 34 | MP0002006_tumorigenesis | 1.71456286 |
| 35 | MP0008260_abnormal_autophagy | 1.64983251 |
| 36 | MP0001819_abnormal_immune_cell | 1.63560393 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.62909119 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.61463796 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.60473651 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.59912058 |
| 41 | MP0004510_myositis | 1.57187104 |
| 42 | MP0002398_abnormal_bone_marrow | 1.56865249 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.53952626 |
| 44 | MP0002396_abnormal_hematopoietic_system | 1.51924744 |
| 45 | MP0001873_stomach_inflammation | 1.50965862 |
| 46 | MP0003453_abnormal_keratinocyte_physiol | 1.50147124 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.50047608 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.49912125 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.48007430 |
| 50 | MP0000609_abnormal_liver_physiology | 1.44840208 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.44710238 |
| 52 | MP0000716_abnormal_immune_system | 1.44625997 |
| 53 | MP0010352_gastrointestinal_tract_polyps | 1.43558985 |
| 54 | MP0001853_heart_inflammation | 1.43243633 |
| 55 | MP0008469_abnormal_protein_level | 1.39138157 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.38143238 |
| 57 | MP0002722_abnormal_immune_system | 1.36385516 |
| 58 | MP0008875_abnormal_xenobiotic_pharmacok | 1.34450442 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.32777169 |
| 60 | MP0008057_abnormal_DNA_replication | 1.32189277 |
| 61 | MP0010329_abnormal_lipoprotein_level | 1.28919885 |
| 62 | MP0003252_abnormal_bile_duct | 1.27828140 |
| 63 | MP0002429_abnormal_blood_cell | 1.25744696 |
| 64 | MP0005174_abnormal_tail_pigmentation | 1.23023327 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 1.18724588 |
| 66 | MP0005083_abnormal_biliary_tract | 1.17737028 |
| 67 | MP0005166_decreased_susceptibility_to | 1.16563536 |
| 68 | MP0009764_decreased_sensitivity_to | 1.14767005 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.14189047 |
| 70 | MP0004381_abnormal_hair_follicle | 1.13283621 |
| 71 | MP0003866_abnormal_defecation | 1.12166396 |
| 72 | MP0005319_abnormal_enzyme/_coenzyme | 1.09979871 |
| 73 | MP0003566_abnormal_cell_adhesion | 1.09510757 |
| 74 | MP0003690_abnormal_glial_cell | 1.08139403 |
| 75 | MP0002009_preneoplasia | 1.08053065 |
| 76 | MP0002254_reproductive_system_inflammat | 1.08011263 |
| 77 | MP0001851_eye_inflammation | 1.07848436 |
| 78 | MP0005023_abnormal_wound_healing | 1.07268052 |
| 79 | MP0000604_amyloidosis | 1.05326204 |
| 80 | MP0001666_abnormal_nutrient_absorption | 1.04929783 |
| 81 | MP0003091_abnormal_cell_migration | 1.04164626 |
| 82 | MP0003045_fibrosis | 1.04150695 |
| 83 | MP0000858_altered_metastatic_potential | 1.02975019 |
| 84 | MP0000703_abnormal_thymus_morphology | 1.00851803 |
| 85 | MP0003448_altered_tumor_morphology | 1.00005874 |
| 86 | MP0000490_abnormal_crypts_of | 0.98976046 |
| 87 | MP0002132_abnormal_respiratory_system | 0.98914995 |
| 88 | MP0004883_abnormal_blood_vessel | 0.97842628 |
| 89 | MP0005075_abnormal_melanosome_morpholog | 0.97127016 |
| 90 | MP0000598_abnormal_liver_morphology | 0.96975314 |
| 91 | MP0005076_abnormal_cell_differentiation | 0.96705657 |
| 92 | MP0000343_altered_response_to | 0.96060367 |
| 93 | MP0003828_pulmonary_edema | 0.94425761 |
| 94 | MP0009763_increased_sensitivity_to | 0.93512693 |
| 95 | MP0000371_diluted_coat_color | 0.93511206 |
| 96 | MP0001663_abnormal_digestive_system | 0.93429878 |
| 97 | MP0005390_skeleton_phenotype | 0.92883910 |
| 98 | MP0002933_joint_inflammation | 0.90712741 |
| 99 | MP0010307_abnormal_tumor_latency | 0.87435485 |
| 100 | MP0004019_abnormal_vitamin_homeostasis | 0.87280623 |
| 101 | MP0005332_abnormal_amino_acid | 0.86927834 |
| 102 | MP0004808_abnormal_hematopoietic_stem | 0.86736522 |
| 103 | MP0003806_abnormal_nucleotide_metabolis | 0.86361255 |
| 104 | MP0002019_abnormal_tumor_incidence | 0.85965378 |
| 105 | MP0005164_abnormal_response_to | 0.85796646 |
| 106 | MP0002118_abnormal_lipid_homeostasis | 0.85323921 |
| 107 | MP0001849_ear_inflammation | 0.84500256 |
| 108 | MP0009643_abnormal_urine_homeostasis | 0.84381489 |
| 109 | MP0003075_altered_response_to | 0.84251040 |
| 110 | MP0002060_abnormal_skin_morphology | 0.80307908 |
| 111 | MP0003186_abnormal_redox_activity | 0.80024192 |
| 112 | MP0009115_abnormal_fat_cell | 0.79147572 |
| 113 | MP0000249_abnormal_blood_vessel | 0.78818801 |
| 114 | MP0002877_abnormal_melanocyte_morpholog | 0.78752799 |
| 115 | MP0000465_gastrointestinal_hemorrhage | 0.76433792 |
| 116 | MP0008004_abnormal_stomach_pH | 0.75963678 |
| 117 | MP0005310_abnormal_salivary_gland | 0.74925184 |
| 118 | MP0002796_impaired_skin_barrier | 0.74899247 |
| 119 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74591307 |
| 120 | MP0008874_decreased_physiological_sensi | 0.74539029 |
| 121 | MP0004858_abnormal_nervous_system | 0.74421116 |
| 122 | MP0003279_aneurysm | 0.73185159 |
| 123 | MP0003795_abnormal_bone_structure | 0.71689232 |
| 124 | MP0005666_abnormal_adipose_tissue | 0.68422411 |
| 125 | MP0005381_digestive/alimentary_phenotyp | 0.61490643 |
| 126 | MP0002277_abnormal_respiratory_mucosa | 0.59736774 |
| 127 | MP0001958_emphysema | 0.57994520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pustule (HP:0200039) | 4.60912467 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 3.94972085 |
| 3 | Optic neuritis (HP:0100653) | 3.94972085 |
| 4 | Increased IgM level (HP:0003496) | 3.93540649 |
| 5 | Nasal polyposis (HP:0100582) | 3.80339274 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 3.72628939 |
| 7 | Chronic otitis media (HP:0000389) | 3.70780538 |
| 8 | Abnormality of the nasal mucosa (HP:0000433) | 3.68516789 |
| 9 | Eczematoid dermatitis (HP:0000976) | 3.62531313 |
| 10 | Myocardial infarction (HP:0001658) | 3.36622238 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.35855693 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.23486831 |
| 13 | Gingivitis (HP:0000230) | 3.14070534 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 3.13974149 |
| 15 | Obstructive lung disease (HP:0006536) | 3.13974149 |
| 16 | Stomatitis (HP:0010280) | 3.10934541 |
| 17 | Recurrent abscess formation (HP:0002722) | 3.05213005 |
| 18 | Colitis (HP:0002583) | 3.03824770 |
| 19 | Mucopolysacchariduria (HP:0008155) | 3.00015839 |
| 20 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.00015839 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 2.93182752 |
| 22 | Myositis (HP:0100614) | 2.91524366 |
| 23 | Keratoconjunctivitis sicca (HP:0001097) | 2.91354477 |
| 24 | Recurrent viral infections (HP:0004429) | 2.90648907 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.88415560 |
| 26 | Polycythemia (HP:0001901) | 2.87109315 |
| 27 | Abnormality of T cell number (HP:0011839) | 2.85988456 |
| 28 | Malnutrition (HP:0004395) | 2.82992477 |
| 29 | Pulmonary infiltrates (HP:0002113) | 2.81664902 |
| 30 | Encephalitis (HP:0002383) | 2.81556429 |
| 31 | T lymphocytopenia (HP:0005403) | 2.81496509 |
| 32 | Dysostosis multiplex (HP:0000943) | 2.81399045 |
| 33 | Loss of speech (HP:0002371) | 2.79345274 |
| 34 | Gastrointestinal stroma tumor (HP:0100723) | 2.78819621 |
| 35 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.77340331 |
| 36 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.77340331 |
| 37 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.77340331 |
| 38 | Abnormality of T cells (HP:0002843) | 2.77140606 |
| 39 | Xanthomatosis (HP:0000991) | 2.74615536 |
| 40 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.73860113 |
| 41 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.72883623 |
| 42 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.72883623 |
| 43 | Abnormality of glycolipid metabolism (HP:0010969) | 2.72883623 |
| 44 | Abnormality of T cell physiology (HP:0011840) | 2.70912525 |
| 45 | Albinism (HP:0001022) | 2.70172467 |
| 46 | Recurrent bronchitis (HP:0002837) | 2.68999936 |
| 47 | Hemoptysis (HP:0002105) | 2.68835725 |
| 48 | Poikiloderma (HP:0001029) | 2.67938052 |
| 49 | Deep venous thrombosis (HP:0002625) | 2.66438279 |
| 50 | Joint hemorrhage (HP:0005261) | 2.64756261 |
| 51 | Alopecia of scalp (HP:0002293) | 2.63921226 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.63768182 |
| 53 | Gingival bleeding (HP:0000225) | 2.62116358 |
| 54 | Keratoconjunctivitis (HP:0001096) | 2.60822578 |
| 55 | Hypochromic anemia (HP:0001931) | 2.60473341 |
| 56 | Agammaglobulinemia (HP:0004432) | 2.59556127 |
| 57 | Gastrointestinal inflammation (HP:0004386) | 2.59192843 |
| 58 | Epistaxis (HP:0000421) | 2.57445318 |
| 59 | Vacuolated lymphocytes (HP:0001922) | 2.55762541 |
| 60 | Abnormal platelet volume (HP:0011876) | 2.53494643 |
| 61 | Systemic lupus erythematosus (HP:0002725) | 2.53074879 |
| 62 | IgA deficiency (HP:0002720) | 2.49657573 |
| 63 | Hypergammaglobulinemia (HP:0010702) | 2.47495067 |
| 64 | Intrahepatic cholestasis (HP:0001406) | 2.46452932 |
| 65 | Hypobetalipoproteinemia (HP:0003563) | 2.44943194 |
| 66 | Emphysema (HP:0002097) | 2.44738945 |
| 67 | Complement deficiency (HP:0004431) | 2.42708704 |
| 68 | Prolonged bleeding time (HP:0003010) | 2.42630052 |
| 69 | Purpura (HP:0000979) | 2.42504527 |
| 70 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.40980605 |
| 71 | Increased cerebral lipofuscin (HP:0011813) | 2.40709817 |
| 72 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.40413063 |
| 73 | Increased mean platelet volume (HP:0011877) | 2.39749968 |
| 74 | Ulnar bowing (HP:0003031) | 2.39415514 |
| 75 | Orchitis (HP:0100796) | 2.36270314 |
| 76 | Menorrhagia (HP:0000132) | 2.36060474 |
| 77 | Chest pain (HP:0100749) | 2.35880370 |
| 78 | Spontaneous hematomas (HP:0007420) | 2.35456936 |
| 79 | Hypochromic microcytic anemia (HP:0004840) | 2.34201143 |
| 80 | Abnormality of macrophages (HP:0004311) | 2.32105311 |
| 81 | Osteomyelitis (HP:0002754) | 2.28583156 |
| 82 | Interstitial pulmonary disease (HP:0006530) | 2.28272413 |
| 83 | Thrombocytosis (HP:0001894) | 2.26722203 |
| 84 | Recurrent skin infections (HP:0001581) | 2.26350032 |
| 85 | Glomerulonephritis (HP:0000099) | 2.25548953 |
| 86 | Pulmonary embolism (HP:0002204) | 2.23434626 |
| 87 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.22678672 |
| 88 | Vasculitis (HP:0002633) | 2.19934025 |
| 89 | Abnormality of complement system (HP:0005339) | 2.18980917 |
| 90 | Lymphopenia (HP:0001888) | 2.17940623 |
| 91 | Impaired platelet aggregation (HP:0003540) | 2.17900911 |
| 92 | Abnormal platelet function (HP:0011869) | 2.17900911 |
| 93 | Nephritis (HP:0000123) | 2.17576992 |
| 94 | Periodontitis (HP:0000704) | 2.17345843 |
| 95 | Hemorrhage of the eye (HP:0011885) | 2.16680334 |
| 96 | Increased IgE level (HP:0003212) | 2.15511291 |
| 97 | Abnormality of the common coagulation pathway (HP:0010990) | 2.14944856 |
| 98 | Restrictive lung disease (HP:0002091) | 2.13974004 |
| 99 | Amyloidosis (HP:0011034) | 2.13852400 |
| 100 | Mediastinal lymphadenopathy (HP:0100721) | 2.13212232 |
| 101 | Premature loss of primary teeth (HP:0006323) | 2.11528855 |
| 102 | Asymmetric septal hypertrophy (HP:0001670) | 2.11093238 |
| 103 | Anorexia (HP:0002039) | 2.09818913 |
| 104 | Granulocytopenia (HP:0001913) | 2.08149062 |
| 105 | Abnormal hemoglobin (HP:0011902) | 2.07389189 |
| 106 | Prolonged partial thromboplastin time (HP:0003645) | 2.06960101 |
| 107 | IgM deficiency (HP:0002850) | 2.06605375 |
| 108 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.05610510 |
| 109 | Cheilitis (HP:0100825) | 2.03902285 |
| 110 | Increased serum ferritin (HP:0003281) | 2.03826196 |
| 111 | Combined immunodeficiency (HP:0005387) | 2.03799732 |
| 112 | Esophageal varix (HP:0002040) | 2.03577371 |
| 113 | Abnormality of the pleura (HP:0002103) | 2.02781203 |
| 114 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.02571860 |
| 115 | Joint swelling (HP:0001386) | 2.00793792 |
| 116 | Cellulitis (HP:0100658) | 1.99962289 |
| 117 | Thin bony cortex (HP:0002753) | 1.99542690 |
| 118 | Recurrent cutaneous fungal infections (HP:0011370) | 1.99376736 |
| 119 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.99376736 |
| 120 | Hyperlipoproteinemia (HP:0010980) | 1.99183673 |
| 121 | Sepsis (HP:0100806) | 1.98488479 |
| 122 | Cerebral aneurysm (HP:0004944) | 1.96959877 |
| 123 | Obstructive sleep apnea (HP:0002870) | 1.96893998 |
| 124 | Hepatosplenomegaly (HP:0001433) | 1.96630032 |
| 125 | Abnormality of iron homeostasis (HP:0011031) | 1.96127879 |
| 126 | Leukocytosis (HP:0001974) | 1.95752308 |
| 127 | Polygenic inheritance (HP:0010982) | 1.95555931 |
| 128 | Gangrene (HP:0100758) | 1.95513243 |
| 129 | Skin ulcer (HP:0200042) | 1.94057240 |
| 130 | Hematochezia (HP:0002573) | 1.93572121 |
| 131 | Arterial thrombosis (HP:0004420) | 1.92072163 |
| 132 | Lower limb hyperreflexia (HP:0002395) | 1.91070226 |
| 133 | Microcytic anemia (HP:0001935) | 1.91031719 |
| 134 | IgG deficiency (HP:0004315) | 1.89681840 |
| 135 | Urticaria (HP:0001025) | 1.87893918 |
| 136 | Meningitis (HP:0001287) | 1.87541883 |
| 137 | Panhypogammaglobulinemia (HP:0003139) | 1.87442638 |
| 138 | Autoimmune hemolytic anemia (HP:0001890) | 1.87234832 |
| 139 | Severe combined immunodeficiency (HP:0004430) | 1.86693980 |
| 140 | Petechiae (HP:0000967) | 1.86382383 |
| 141 | Arthralgia (HP:0002829) | 1.86117087 |
| 142 | Growth hormone excess (HP:0000845) | 1.85279046 |
| 143 | Hypertriglyceridemia (HP:0002155) | 1.85192972 |
| 144 | Gastrointestinal infarctions (HP:0005244) | 1.84541931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.25482747 |
| 2 | MAP4K1 | 3.22717817 |
| 3 | TYK2 | 2.92605324 |
| 4 | PRPF4B | 2.86942052 |
| 5 | ERN1 | 2.75150734 |
| 6 | CSK | 2.55068055 |
| 7 | FGFR4 | 2.53436564 |
| 8 | TBK1 | 2.36302327 |
| 9 | JAK3 | 2.35232937 |
| 10 | MAPK15 | 2.28291387 |
| 11 | ICK | 2.26792985 |
| 12 | MAP3K14 | 2.18209730 |
| 13 | IKBKE | 2.17118512 |
| 14 | TNK2 | 2.08457919 |
| 15 | JAK1 | 2.01337254 |
| 16 | MAP3K11 | 1.98597707 |
| 17 | MAP3K6 | 1.97543995 |
| 18 | TRIB3 | 1.96036001 |
| 19 | MAP3K10 | 1.91342216 |
| 20 | MATK | 1.90921517 |
| 21 | PIM2 | 1.87789636 |
| 22 | KIT | 1.83068424 |
| 23 | BLK | 1.71240225 |
| 24 | DDR2 | 1.66237973 |
| 25 | ZAP70 | 1.63409337 |
| 26 | IKBKB | 1.61567171 |
| 27 | SMG1 | 1.54150903 |
| 28 | TAOK1 | 1.51577390 |
| 29 | FES | 1.51321495 |
| 30 | PIM1 | 1.51000414 |
| 31 | TAOK3 | 1.50974034 |
| 32 | BMX | 1.48950086 |
| 33 | FGR | 1.48679930 |
| 34 | TXK | 1.47962469 |
| 35 | TGFBR2 | 1.45316550 |
| 36 | FLT3 | 1.42680016 |
| 37 | SIK1 | 1.31090911 |
| 38 | CDC42BPA | 1.31078915 |
| 39 | STK10 | 1.30209220 |
| 40 | SIK3 | 1.29908789 |
| 41 | PKN2 | 1.28658533 |
| 42 | MAPK11 | 1.27479418 |
| 43 | EPHB1 | 1.26352730 |
| 44 | BTK | 1.24320786 |
| 45 | RIPK1 | 1.24126695 |
| 46 | PRKD2 | 1.23143796 |
| 47 | TRPM7 | 1.22105100 |
| 48 | ITK | 1.19183480 |
| 49 | TAOK2 | 1.18820155 |
| 50 | CDK6 | 1.18641214 |
| 51 | NME2 | 1.18400139 |
| 52 | DYRK1B | 1.15045953 |
| 53 | PDGFRA | 1.14222040 |
| 54 | FGFR3 | 1.12818700 |
| 55 | LCK | 1.12623925 |
| 56 | JAK2 | 1.12502379 |
| 57 | MAP3K1 | 1.11182129 |
| 58 | IRAK3 | 1.07805556 |
| 59 | CHUK | 1.06811836 |
| 60 | GRK6 | 1.06598819 |
| 61 | MARK2 | 1.06329124 |
| 62 | MAP2K3 | 1.06136305 |
| 63 | IRAK4 | 1.05781423 |
| 64 | EEF2K | 1.01819136 |
| 65 | MAP3K13 | 1.00629310 |
| 66 | CSF1R | 0.98880994 |
| 67 | BCKDK | 0.97560687 |
| 68 | KDR | 0.95512381 |
| 69 | SYK | 0.93438117 |
| 70 | RPS6KA6 | 0.90342241 |
| 71 | PINK1 | 0.87571297 |
| 72 | LYN | 0.87514353 |
| 73 | HIPK2 | 0.87157333 |
| 74 | RPS6KC1 | 0.86747323 |
| 75 | RPS6KL1 | 0.86747323 |
| 76 | TTN | 0.85837943 |
| 77 | HCK | 0.85704235 |
| 78 | LRRK2 | 0.85269065 |
| 79 | TESK2 | 0.84940043 |
| 80 | PTK6 | 0.78018299 |
| 81 | DAPK1 | 0.75411752 |
| 82 | TYRO3 | 0.75205865 |
| 83 | GSK3A | 0.74581450 |
| 84 | MAPK7 | 0.74430836 |
| 85 | PDPK1 | 0.72081145 |
| 86 | PDK1 | 0.70778633 |
| 87 | TEC | 0.69946027 |
| 88 | RPS6KA4 | 0.68605458 |
| 89 | EPHA3 | 0.67545507 |
| 90 | GRK7 | 0.66545237 |
| 91 | MAP2K6 | 0.66335466 |
| 92 | MAP3K3 | 0.65494393 |
| 93 | YES1 | 0.65232894 |
| 94 | CDK7 | 0.63724192 |
| 95 | MAPK12 | 0.63474957 |
| 96 | CDK12 | 0.63193702 |
| 97 | IRAK1 | 0.60039260 |
| 98 | NLK | 0.59249504 |
| 99 | MAPK4 | 0.57920039 |
| 100 | EGFR | 0.56929727 |
| 101 | CDK4 | 0.54426360 |
| 102 | NEK9 | 0.53351058 |
| 103 | PRKAA2 | 0.52903197 |
| 104 | RPS6KA2 | 0.51740931 |
| 105 | TESK1 | 0.51451311 |
| 106 | KSR2 | 0.51033285 |
| 107 | IRAK2 | 0.49923212 |
| 108 | TGFBR1 | 0.49866409 |
| 109 | RPS6KA1 | 0.49469654 |
| 110 | FYN | 0.48080226 |
| 111 | MST1R | 0.47308029 |
| 112 | PDGFRB | 0.45518069 |
| 113 | SIK2 | 0.45511057 |
| 114 | CAMKK1 | 0.45205479 |
| 115 | CAMK1D | 0.44631604 |
| 116 | STK4 | 0.44615499 |
| 117 | RPS6KB2 | 0.43981341 |
| 118 | MTOR | 0.43363559 |
| 119 | MAPKAPK2 | 0.41826668 |
| 120 | MAP3K7 | 0.40326045 |
| 121 | ABL1 | 0.40020512 |
| 122 | MAPK3 | 0.38374886 |
| 123 | BMPR2 | 0.38274135 |
| 124 | MAPKAPK3 | 0.37904979 |
| 125 | PTK2 | 0.36747600 |
| 126 | RET | 0.36269630 |
| 127 | MARK3 | 0.34797876 |
| 128 | MAP2K2 | 0.33915586 |
| 129 | PRKCD | 0.33427061 |
| 130 | MOS | 0.32928523 |
| 131 | PRKCQ | 0.31688568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.82960707 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.58952362 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.48442800 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.28123595 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.22225576 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.08412720 |
| 7 | Measles_Homo sapiens_hsa05162 | 1.96991616 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.94194629 |
| 9 | Asthma_Homo sapiens_hsa05310 | 1.89697584 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.89256508 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.88876228 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.85516548 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.84951202 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.81337612 |
| 15 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.80996490 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.76123162 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.74755378 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.54297484 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.54003610 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.53438323 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.49865305 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.49440437 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.47181640 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.41365393 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.41360947 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.39066844 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.36155342 |
| 28 | ABC transporters_Homo sapiens_hsa02010 | 1.34840529 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.32423047 |
| 30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.28602239 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.23458742 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.20695497 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.19932359 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18376123 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.17962081 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.16919040 |
| 37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14360216 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.13899305 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.13184202 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09806718 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.09783040 |
| 42 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.06572353 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06229175 |
| 44 | Lysine degradation_Homo sapiens_hsa00310 | 1.05761763 |
| 45 | Base excision repair_Homo sapiens_hsa03410 | 1.04227178 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.03940277 |
| 47 | Allograft rejection_Homo sapiens_hsa05330 | 1.02628712 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02470698 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 1.00839804 |
| 50 | Malaria_Homo sapiens_hsa05144 | 0.99470729 |
| 51 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.98577556 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 0.97264949 |
| 53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93807916 |
| 54 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.92311926 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.92130574 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.91960676 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91537193 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.91475360 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.91345212 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.91259831 |
| 61 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.90210671 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.89815253 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88505187 |
| 64 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.88319383 |
| 65 | Hepatitis B_Homo sapiens_hsa05161 | 0.87977874 |
| 66 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87321539 |
| 67 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.83070185 |
| 68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.82785729 |
| 69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.82191077 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81783596 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81761442 |
| 72 | Tuberculosis_Homo sapiens_hsa05152 | 0.81624613 |
| 73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79540493 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.79497457 |
| 75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.79168812 |
| 76 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78722570 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.77083477 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76182264 |
| 79 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.73747001 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.73668237 |
| 81 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72398556 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71288821 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71182021 |
| 84 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70160634 |
| 85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69947675 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.69654305 |
| 87 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69316995 |
| 88 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.68472808 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68102327 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66605061 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.66579728 |
| 92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66301309 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.65371991 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65331129 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64299403 |
| 96 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.63428897 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63189586 |
| 98 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.62624919 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62300591 |
| 100 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61925084 |
| 101 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.61459954 |
| 102 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60925588 |
| 103 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60387857 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58394047 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58285692 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | 0.57590588 |
| 107 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56301296 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.55863947 |
| 109 | Mismatch repair_Homo sapiens_hsa03430 | 0.55483144 |
| 110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54100303 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53495509 |
| 112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52984959 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52198353 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51920282 |
| 115 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.51332836 |
| 116 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51211373 |
| 117 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50978933 |
| 118 | Salmonella infection_Homo sapiens_hsa05132 | 0.50817994 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50405161 |
| 120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49462106 |
| 121 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49342772 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49302339 |
| 123 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47965625 |
| 124 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47351176 |
| 125 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.46925991 |
| 126 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46381618 |
| 127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46333446 |
| 128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44436769 |
| 129 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43398716 |
| 130 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37745274 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37416222 |
| 132 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36787151 |
| 133 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36347258 |
| 134 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35573027 |
| 135 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.35279167 |
| 136 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34013325 |
| 137 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33375829 |
| 138 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32927385 |
| 139 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31578769 |
| 140 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30802053 |
| 141 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26187299 |

